Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. DIHEXA Research Capsules Peptide Tech FDA Peptide Reclassification 2026: What It Means for Providers FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not